Neurocrine Biosciences, Inc. (NBIX)
156.22
-0.35
(-0.22%)
USD |
NASDAQ |
Sep 11, 16:00
156.04
-0.18
(-0.12%)
After-Hours: 20:00
Neurocrine Biosciences Price : 156.22 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 157.20 | 159.67 | 156.12 | 156.22 | 890877.0 |
| Sep 10, 2026 | 154.38 | 159.94 | 152.04 | 156.57 | 895198.0 |
| Sep 09, 2026 | 154.61 | 155.55 | 152.38 | 155.14 | 1.051M |
| Sep 08, 2026 | 153.99 | 156.82 | 151.77 | 155.13 | 820811.0 |
| Sep 04, 2026 | 158.24 | 159.80 | 154.83 | 155.64 | 933570.0 |
| Sep 03, 2026 | 159.93 | 159.93 | 156.76 | 158.35 | 758263.0 |
| Sep 02, 2026 | 157.39 | 160.42 | 155.09 | 157.79 | 1.038M |
| Sep 01, 2026 | 154.31 | 157.03 | 153.70 | 156.76 | 878439.0 |
| Aug 31, 2026 | 153.11 | 155.00 | 151.77 | 154.03 | 1.741M |
| Aug 28, 2026 | 155.92 | 156.57 | 153.08 | 154.06 | 812988.0 |
| Aug 27, 2026 | 155.28 | 156.75 | 154.61 | 155.92 | 730293.0 |
| Aug 26, 2026 | 153.21 | 159.40 | 152.02 | 156.59 | 1.119M |
| Aug 25, 2026 | 153.84 | 156.13 | 152.00 | 153.37 | 1.042M |
| Aug 24, 2026 | 152.57 | 154.56 | 151.77 | 153.04 | 1.208M |
| Aug 21, 2026 | 153.13 | 155.26 | 152.51 | 152.57 | 1.228M |
| Aug 20, 2026 | 154.99 | 155.81 | 152.50 | 152.93 | 870659.0 |
| Aug 19, 2026 | 156.56 | 156.56 | 154.34 | 155.54 | 1.163M |
| Aug 18, 2026 | 155.92 | 156.24 | 153.46 | 154.23 | 1.038M |
| Aug 17, 2026 | 151.62 | 154.81 | 150.69 | 154.49 | 1.169M |
| Aug 14, 2026 | 149.72 | 153.42 | 148.78 | 152.72 | 1.305M |
| Aug 13, 2026 | 154.43 | 155.81 | 150.20 | 150.82 | 2.056M |
| Aug 12, 2026 | 159.74 | 159.98 | 154.86 | 156.49 | 2.094M |
| Aug 11, 2026 | 165.46 | 165.46 | 161.78 | 161.94 | 808120.0 |
| Aug 10, 2026 | 161.52 | 165.15 | 161.52 | 164.92 | 935227.0 |
| Aug 07, 2026 | 161.53 | 164.76 | 159.68 | 163.41 | 971006.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amarin Corp. Plc | 13.80 |
| Liquidia Corp. | 66.74 |
| BioCryst Pharmaceuticals, Inc. | 8.12 |
| Halozyme Therapeutics, Inc. | 107.20 |
| Iovance Biotherapeutics, Inc. | 8.60 |
Price Related Metrics
| PE Ratio | 22.89 |
| PS Ratio | 4.79 |
| PEG Ratio | 0.2255 |
| Price to Book Value | 4.297 |
| Price to Free Cash Flow | 19.90 |
| Earnings Yield | 4.37% |
| Market Cap | 15.87B |
| PEGY Ratio | 0.2255 |
| Operating PE Ratio | 20.05 |
| Normalized PE Ratio | 23.35 |